内镜经鼻与开颅入路治疗嗅沟脑膜瘤的系统综述与Meta分析
该Meta分析纳入8项研究(n=382),比较内镜经鼻入路(EEA)与开颅入路(TCA)治疗嗅沟脑膜瘤。EEA的脑脊液漏风险显著高于TCA(OR 5.36,95%CI 1.64-17.5),但全切除率与复发率无显著差异;EEA多用于较小肿瘤,TCA多用于较大肿瘤,入路选择应个体化。
要点
- EEA与TCA的全切除率(OR 0.71,95%CI 0.23-2.19)和复发率(OR 1.63,95%CI 0.60-4.45)无显著差异。
- EEA的脑脊液漏风险显著高于TCA(OR 5.36,95%CI 1.64-17.5)。
- EEA多用于较小肿瘤,TCA多用于较大肿瘤;入路选择应基于肿瘤解剖与术者经验个体化。
核心结论
- 两种入路均有效,但比较受选择偏倚限制;EEA脑脊液漏风险更高,全切除与复发相当。
- TCA在复杂肿瘤中实现更一致的全切除。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、Embase、Web of Science、Scopus和Cochrane Library(2000-2024年)。
- 纳入8项研究,共382例患者,报告EEA与TCA的结局。
主要发现
- 3项比较研究的汇总分析显示全切除率无显著差异(OR 0.71,95%CI 0.23-2.19,I2=0%)。
- 复发率无显著差异(OR 1.63,95%CI 0.60-4.45,I2=0%)。
- EEA与更高的脑脊液漏风险相关(OR 5.36,95%CI 1.64-17.5,I2=0%)。
- EEA全切除率范围82%-96%,TCA为86%-100%;脑脊液漏率分别为16%-30%和2%-7%。
- 视觉结局相当或倾向于EEA。
关键数值与推荐
- EEA全切除率范围82%-96%,TCA为86%-100%。
- EEA脑脊液漏率范围16%-30%,TCA为2%-7%。
临床怎么用
- EEA适用于较小肿瘤,TCA适用于较大复杂肿瘤,入路选择应个体化基于肿瘤解剖和术者经验。
局限性
- 比较受选择偏倚限制,因肿瘤解剖决定入路选择。
- 纳入研究数量有限(8项),部分结局仅基于3项比较研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal surgical approach for olfactory groove meningiomas (OGMs) remains debated. Comparisons between the endoscopic endonasal approach (EEA) and transcranial approach (TCA) are limited by confounding by indication, as tumor anatomy dictates approach selection. This meta-analysis synthesizes evidence while addressing these limitations. METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed, Embase, Web of Science, Scopus, and Cochrane Library were searched (2000-2024). Studies reporting EEA and TCA outcomes were included. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model, with heterogeneity assessed using I2. Outcomes included gross total resection (GTR), visual outcomes, CSF leak, complications, and recurrence. RESULTS: Eight studies (n = 382) were included. Pooled analysis of 3 comparative studies showed no significant difference in GTR (OR: 0.71, 95% CI: 0.23-2.19, I2 = 0%) or recurrence (OR: 1.63, 95% CI: 0.60-4.45, I2 = 0%). EEA was associated with higher odds of CSF leak (OR: 5.36, 95% CI 1.64-17.5, I2 = 0%). GTR rates ranged from 82%-96% for EEA and 86%-100% for TCA, while CSF leak rates were 16%-30% and 2%-7%, respectively. Visual outcomes were comparable or favored EEA. EEA was mainly used for smaller tumors, while TCA was used for larger lesions. CONCLUSIONS: Both approaches are effective, but comparisons are limited by selection bias. EEA carries a higher CSF leak risk, while GTR and recurrence are comparable. TCA achieves more consistent GTR in complex tumors. Approach selection should be individualized based on tumor anatomy and surgeon expertise.
引用
- Hafiz B, Alsharif T, Okal F, et al. Comparative Efficacy of Endoscopic Endonasal versus Transcranial Approaches for Treating Olfactory Groove Meningiomas: A Systematic Review and Meta-Analysis. World Neurosurg. 2026. PMID: 42061507. doi:10.1016/j.wneu.2026.125015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。